Glyburide
Product Images NDC 53002-4170

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 53002-4170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Dde70749 E2c1 4ba6 Bdba F08a456e803c 01)

Image (Dde70749 E2c1 4ba6 Bdba F08a456e803c 01)
Chemical structure of glyburide displaying various chemical groups including chlorine, methoxy, sulfonylurea, and cyclohexyl moieties arranged in its molecular framework.*
FDA Label Image

Label Image (Lbl530024170)

Label Image (Lbl530024170)
GLYBURIDE 5 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label shows a 30-tablet bottle with instructions to take one tablet daily or as directed. Includes sections for patient and prescriber information, drug storage, and warnings about blood sugar control. The label also displays NDC 53002-4170 and lot number fields, with a barcode and Rx-only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.